recurrent mantle cell lymphoma

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
Jan 15, 2020

Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia Trial in

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • +20 more
  • Atorvastatin Calcium
  • +7 more
  • Denver, Colorado
  • +1 more
Dec 26, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in United States (procedure, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +25 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +5 more
Dec 17, 2019

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Recurrent Mantle Cell Lymphoma Trial in United States (rituximab, temsirolimus)

Completed
  • Recurrent Mantle Cell Lymphoma
  • Mobile, Alabama
  • +194 more
Mar 21, 2014